Farms.com Home   Ag Industry News

”Roundup is not a carcinogen,” says Monsanto CEO

Part 2 of Hugh Grant’s interview with Here & Now

By Diego Flammini
Assistant Editor, North American Content
Farms.com

On Thursday, Monsanto CEO Hugh Grant joined Here & Now in Boston for a two-part interview to discuss various issues in the ag industry.

In Part 1, Grant discussed GMOs, strategies to make agriculture more sustainable and consumer concerns with host Jeremy Hobson.

Part 2 sees Grant touch on a variety of topics including Monsanto and Roundup’s places in the global landscape.

When it comes to those who believe Roundup is a cancer-causing product, Grant’s answer was direct.

“Roundup is not a carcinogen,” he said during the interview.

Grant said the product has been tested and reviewed nearly each of its 40-year existence. According to Grant, Europe’s review of the product was “glowing,” Canada is currently conducting its review and the United States will conduct its own as well.

“I’ve absolutely no concerns about the safety of the product,” he said.

Despite being the head of a company that makes chemical products, Grant says the future of agriculture will depend on a cooperative effort from organic and conventional farmers, especially as infrastructure continues to develop.

“As urbanization increases, we’re going to need all kinds of agriculture,” he said. “It’s framed somehow as big versus little, or organic verses conventional. We’re going to need everybody at the table.”


Trending Video

Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Video: Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Genetic research and new technologies continue to influence the future of swine health and production efficiency. In this episode, we explore how research and technology are being used to support stronger, more resilient pigs, while also improving overall production outcomes. In this episode, we are joined by Dr. Jenelle Dunkelberger, geneticist with Topigs Norsvin, to discuss both routine and emerging strategies for improving piglet, pig, and sow livability. She outlines two primary approaches to enhancing resiliency: gene editing and traditional selective breeding. Continuing the resiliency conversation, we also hear from Dr. Lucina Galina, director of technical research projects at the Pig Improvement Company. She shares insights into ongoing gene-editing work focused on PRRS, detailing the pathway to success, regulatory and practical considerations, and the questions that still remain as the technology evolves. Together, these conversations provide a closer look at how research, genetics and innovation are shaping the future of swine health and livability.